Antimicrobial Market Demand Signals
Recent earnings reports across antimicrobial-focused biopharma companies are offering a more nuanced view of demand in a market long considered commercially fragile. While antimicrobial resistance continues to escalate globally, revenue signals from 2025 and early 2026 suggest that demand is not only stable but increasingly differentiated across hospital, specialty, and novel antibiotic segments. Shift to … Read more